z-logo
open-access-imgOpen Access
Prescribing SGLT2 Inhibitors in Patients With CKD: Expanding Indications and Practical Considerations
Author(s) -
Kevin Yau,
Atit Dharia,
Ibrahim Alrowiyti,
David Z.I. Cherney
Publication year - 2022
Publication title -
kidney international reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.225
H-Index - 22
ISSN - 2468-0249
DOI - 10.1016/j.ekir.2022.08.016
Subject(s) - dapagliflozin , medicine , diuretic , heart failure , placebo , concomitant , ejection fraction , kidney disease , renal function , intensive care medicine , endocrinology , diabetes mellitus , alternative medicine , type 2 diabetes , pathology

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom